Release Date	Request Code	Change Type	NCI Code	CDISC Term Type	CDISC Codelist (Short Name)	CDISC Codelist (Long Name)	Change Summary	Original	New
10/4/2013	N/A	I	C42993	Definition	CDASH-CMDOSFRM	Concomitant Medication Dose Form	Update to Definition for consistency with SDTM	A solid body of various weights and shapes, adapted for introduction into the rectal orifice of the human body; they usually melt, soften, or dissolve at body temperature.	A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature.
10/4/2013	N/A	I	C48152	Definition	CDASH-CMDOSU	Concomitant Medication Dose Units	Update to Definition for consistency with SDTM	A unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)	The unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)
10/4/2013	32505	II	C38299	Synonym	CDASH-CMROUTE	Concomitant Medication Route of Administration	Addition of a synonym	SC	SC; Subdermal Route of Administration
10/4/2013	N/A	I	C38299	Definition	CDASH-CMROUTE	Concomitant Medication Route of Administration	Add space between period and FDA citation.	Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.(FDA)	Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL. (FDA)
10/4/2013	N/A	I	C38299	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Subcutaneous Route of Drug Administration	Subcutaneous Route of Administration
10/4/2013	N/A	I	C38216	Definition	CDASH-CMROUTE	Concomitant Medication Route of Administration	Add space between period and FDA citation.	Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.(FDA)	Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect. (FDA)
10/4/2013	N/A	I	C38250	Definition	CDASH-CMROUTE	Concomitant Medication Route of Administration	Add space between period and FDA citation.	Administration within or introduced directly into a localized lesion.(FDA)	Administration within or introduced directly into a localized lesion. (FDA)
10/4/2013	N/A	I	C38255	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Intraocular Route of Drug Administration	Intraocular Route of Administration
10/4/2013	N/A	I	C38255	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Add space between period and FDA citation.	Administration within the eye.(FDA)	Administration within the eye. (FDA)
10/4/2013	N/A	I	C38258	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Add space between period and FDA citation.	Administration within the peritoneal cavity.(FDA)	Administration within the peritoneal cavity. (FDA)
10/4/2013	N/A	I	C38258	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Intraperitoneal Route of Drug Administration	Intraperitoneal Route of Administration
10/4/2013	N/A	I	C38284	Definition	CDASH-CMROUTE	Concomitant Medication Route of Administration	Add space between period and FDA citation.	Administration to the nose; administered by way of the nose.(FDA)	Administration to the nose; administered by way of the nose. (FDA)
10/4/2013	N/A	I	C38284	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Nasal Route of Drug Administration	Nasal Route of Administration
10/4/2013	N/A	I	C38288	Definition	CDASH-CMROUTE	Concomitant Medication Route of Administration	Add space between period and FDA citation.	Administration to or by way of the mouth.(FDA)	Administration to or by way of the mouth. (FDA)
10/4/2013	N/A	I	C38288	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Oral Route of Drug administration	Oral Route of Administration
10/4/2013	N/A	I	C38305	Definition	CDASH-CMROUTE	Concomitant Medication Route of Administration	Add space between period and FDA citation.	Administration through the dermal layer of the skin to the systemic circulation by diffusion.(FDA)	Administration through the dermal layer of the skin to the systemic circulation by diffusion. (FDA)
10/4/2013	N/A	I	C38305	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Transdermal Route of Drug Administration	Transdermal Route of Administration
10/4/2013	N/A	I	C38313	Definition	CDASH-CMROUTE	Concomitant Medication Route of Administration	Add space between period and FDA citation.	Administration into the vagina.(FDA)	Administration into the vagina. (FDA)
10/4/2013	N/A	I	C38313	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Vaginal Route of Drug Administration	Vaginal Route of Administration
10/4/2013	N/A	I	C38304	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Topical Route of Drug Administration	Topical Route of Administration
10/4/2013	N/A	I	C38255	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Intraocular Route of Drug Administration	Intraocular Route of Administration
10/4/2013	N/A	I	C38250	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Intralesional Route of Drug Administration	Intralesional Route of Administration
10/4/2013	N/A	I	C38295	NCI Preferred Term	CDASH-CMROUTE	Concomitant Medication Route of Administration	Update to NCI Preferred Term	Rectal Route of Drug Administration	Rectal Route of Administration
10/4/2013	N/A	I	C42993	Definition	CDASH-EXDOSFRM	Exposure Dose Form	Update to Definition for consistency with SDTM	A solid body of various weights and shapes, adapted for introduction into the rectal orifice of the human body; they usually melt, soften, or dissolve at body temperature.	A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature.
10/4/2013	N/A	I	C48152	Definition	CDASH-EXDOSU	Units for Exposure	Update to Definition for consistency with SDTM	A unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)	The unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)
10/4/2013	N/A	I	C48152	Definition	CDASH-EXPDOSEU	Units for Planned Exposure	Update to Definition for consistency with SDTM	A unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)	The unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)
10/4/2013	32505	II	C38299	Synonym	CDASH-EXROUTE	Exposure Route of Administration	Addition of a synonym	SC	SC; Subdermal Route of Administration
10/4/2013	N/A	I	C38299	Definition	CDASH-EXROUTE	Exposure Route of Administration	Add space between period and FDA citation.	Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.(FDA)	Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL. (FDA)
10/4/2013	N/A	I	C38299	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Subcutaneous Route of Drug Administration	Subcutaneous Route of Administration
10/4/2013	N/A	I	C38216	Definition	CDASH-EXROUTE	Exposure Route of Administration	Add space between period and FDA citation.	Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.(FDA)	Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect. (FDA)
10/4/2013	N/A	I	C38250	Definition	CDASH-EXROUTE	Exposure Route of Administration	Add space between period and FDA citation.	Administration within or introduced directly into a localized lesion.(FDA)	Administration within or introduced directly into a localized lesion. (FDA)
10/4/2013	N/A	I	C38255	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Intraocular Route of Drug Administration	Intraocular Route of Administration
10/4/2013	N/A	I	C38255	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Add space between period and FDA citation.	Administration within the eye.(FDA)	Administration within the eye. (FDA)
10/4/2013	N/A	I	C38258	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Add space between period and FDA citation.	Administration within the peritoneal cavity.(FDA)	Administration within the peritoneal cavity. (FDA)
10/4/2013	N/A	I	C38258	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Intraperitoneal Route of Drug Administration	Intraperitoneal Route of Administration
10/4/2013	N/A	I	C38284	Definition	CDASH-EXROUTE	Exposure Route of Administration	Add space between period and FDA citation.	Administration to the nose; administered by way of the nose.(FDA)	Administration to the nose; administered by way of the nose. (FDA)
10/4/2013	N/A	I	C38284	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Nasal Route of Drug Administration	Nasal Route of Administration
10/4/2013	N/A	I	C38288	Definition	CDASH-EXROUTE	Exposure Route of Administration	Add space between period and FDA citation.	Administration to or by way of the mouth.(FDA)	Administration to or by way of the mouth. (FDA)
10/4/2013	N/A	I	C38288	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Oral Route of Drug administration	Oral Route of Administration
10/4/2013	N/A	I	C38305	Definition	CDASH-EXROUTE	Exposure Route of Administration	Add space between period and FDA citation.	Administration through the dermal layer of the skin to the systemic circulation by diffusion.(FDA)	Administration through the dermal layer of the skin to the systemic circulation by diffusion. (FDA)
10/4/2013	N/A	I	C38305	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Transdermal Route of Drug Administration	Transdermal Route of Administration
10/4/2013	N/A	I	C38313	Definition	CDASH-EXROUTE	Exposure Route of Administration	Add space between period and FDA citation.	Administration into the vagina.(FDA)	Administration into the vagina. (FDA)
10/4/2013	N/A	I	C38313	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Vaginal Route of Drug Administration	Vaginal Route of Administration
10/4/2013	N/A	I	C38304	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Topical Route of Drug Administration	Topical Route of Administration
10/4/2013	N/A	I	C38255	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Intraocular Route of Drug Administration	Intraocular Route of Administration
10/4/2013	N/A	I	C38250	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Intralesional Route of Drug Administration	Intralesional Route of Administration
10/4/2013	N/A	I	C38295	NCI Preferred Term	CDASH-EXROUTE	Exposure Route of Administration	Update to NCI Preferred Term	Rectal Route of Drug Administration	Rectal Route of Administration
10/4/2013	N/A	I	C48152	Definition	CDASH-EXVOLTU	Total Volume Administration Unit	Update to Definition for consistency with SDTM	A unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)	The unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)